Four weeks have passed since I wrote my last blog about gold’s evolving role in diagnosing COVID-19, the pandemic that is affecting us all currently. In that time much has changed, and I wanted to update you all on our thoughts of where things stand in mid-April.
The UK is home for me, and the subject of COVID-19 diagnostics has never been far away from the front pages. The UK government has repeatedly championed the important role antibody testing will play in getting our lives back to normal, as this offers a route to tell whether someone has been infected by COVID-19 and can, therefore, return to work after an appropriate recovery period. As I described previously, these tests can be performed in a centralised laboratory, but this can be a slow and costly process. Having access to a portable, rapid test for point of care settings such as a pharmacy or doctor’s surgery (or potentially even home use) would represent a huge step forward in the fight against COVID-19.